Jan 09, 2019 / 04:00PM GMT
Christopher Thomas Schott - JP Morgan Chase & Co, Research Division - Senior Analyst
Good morning, everybody. I'm Chris Schott from JPMorgan. And it's my pleasure to be introducing AbbVie this morning. From the company, we have recently promoted Vice Chairman and President, Mike Severino. So we welcome Mike to the stage for what I'm sure will be a very interesting presentation. We'll be doing a breakout session afterwards across the hall.
So with that, I turn it over to Mike.
Michael E. Severino - AbbVie Inc. - Vice Chairman & President
Great. So thank you, Chris, and good morning, everyone. It's a pleasure to be here today.
Before I begin, please take a moment to review our forward-looking statement.
Since becoming a public company in 2013, AbbVie's mission has been to create an innovation-driven, patient-focused biopharmaceutical company capable of achieving sustainable, top-tier performance through outstanding execution and a consistent stream of innovative new medicines. We have made tremendous progress advancing our
AbbVie Inc at JPMorgan Global Healthcare Conference Transcript
Jan 09, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers